Completing data — refresh the page later to see the latest
215190-27-5O=C(O)CN1CN(c2ccccc2)C2(CCN(C(=O)OCC3c4ccccc4-c4ccccc43)CC2)C1=OZSJFVKWLUVYERT-UHFFFAOYSA-NSafety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesFmoc-3-carboxymethyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one is used in preparation of α4β1 integrin on Jurkat T-leukemia cells.
215190-27-5DTXSID30373299